{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:45:24Z","timestamp":1790163924911,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bone metastasis is common in breast cancer, but symptomatic bone marrow involvement is exceedingly rare. This report presents a case of a young female patient with triple-negative breast cancer (TNBC) initially presenting with symptomatic bone marrow metastasis. Upon admission, blood tests revealed severe thrombocytopenia. Bone marrow biopsy confirmed tumor cell infiltration, and immunohistochemistry identified metastatic breast cancer cells. The patient received paclitaxel and eribulin chemotherapy combined with transfusion support, achieving significant symptom control. This rare case highlights the importance of early detection and aggressive management in TNBC with bone marrow metastasis.<\/jats:p>","DOI":"10.3389\/fonc.2025.1570355","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:59:16Z","timestamp":1743145156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Symptomatic bone marrow metastasis in triple-negative breast cancer: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Chenhui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.3390\/cancers14184505","article-title":"Leveraging the dynamic immune environment triad in patients with breast cancer: tumour, lymph node, and peripheral blood","volume":"14","author":"Wall","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13062-022-00341-x","article-title":"Long non-coding RNAs affecting cell metabolism in cancer","volume":"17","author":"Agostini","year":"2022","journal-title":"Biol Direct"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/nu14122376","article-title":"Liver metastatic breast cancer: epidemiology, dietary interventions, and related metabolism","volume":"14","author":"Zuo","year":"2022","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v12.9","article-title":"Clinicopathological features and prognosis of breast cancer combined with symptomatic bone marrow metastases: A 10-year, single-center, real-world study of 67 cases","volume":"12","author":"Niu","year":"2023","journal-title":"Cancer Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1430881","article-title":"Case report: Gastric metastasis of breast cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13647","article-title":"Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis","volume":"26","author":"Sakin","year":"2020","journal-title":"Breast J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1042773","article-title":"Symptomatic bone marrow metastases in breast cancer: A retrospective cohort study","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ctrc.2014.11.002","article-title":"Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin","volume":"3","author":"Pahouja","year":"2015","journal-title":"Cancer Treat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15099","article-title":"Successful stabilization of symptomatic bone marrow metastasis two times in a breast cancer patient","volume":"41","author":"Akagi","year":"2021","journal-title":"Anticancer Res"},{"key":"B13","first-page":"99","article-title":"A case of bone marrow carcinomatosis from breast cancer treated with weekly Paclitaxel","volume":"39","author":"Takayama","year":"2012","journal-title":"Gan To Kagaku Ryoho"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.1999","article-title":"Trastuzumab monotherapy for bone marrow metastasis of breast cancer: A case report","volume":"7","author":"Xu","year":"2014","journal-title":"Oncol Lett"},{"key":"B15","article-title":"A case of recurrent breast cancer with bone marrow metastasis treated with weekly paclitaxel therapy","volume":"35","author":"Sasada","year":"2008","journal-title":"Gan To Kagaku Ryoho"},{"key":"B16","article-title":"Symptomatic bone marrow involvement in breast cancer\u2013clinical presentation, treatment, and prognosis: a single institution review of 22 cases","volume":"31","author":"Kopp","year":"2011","journal-title":"Anticancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2022.0381","article-title":"Refeeding syndrome","volume":"120","author":"Heuft","year":"2023","journal-title":"Dtsch Arztebl Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143764","article-title":"Exploiting bone niches: progression of disseminated tumor cells to metastasis","volume":"131","author":"Muscarella","year":"2021","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2405257121","DOI":"10.1073\/pnas.2405257121","article-title":"An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche","volume":"121","author":"Baldassarri","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.3390\/ijms21144967","article-title":"The role of adipokines and bone marrow adipocytes in breast cancer bone metastasis","volume":"21","author":"Shin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2017.07.027","article-title":"Cancer stemness in bone marrow micrometastases of human breast cancer","volume":"163","author":"Kuo","year":"2018","journal-title":"Surgery"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570355\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:59:20Z","timestamp":1743145160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570355\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":21,"alternative-id":["10.3389\/fonc.2025.1570355"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1570355","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"1570355"}}